Quote | Super Quote
IPO   |   IPO News   |   Listed IPO Information   |   Hot Listed IPO
Stock Code   IPO News IPO Timetable
IPO News

13/05/2026 09:20

METIS TECHBIO-P opens up 173.14% at HK$28.68

  [ET Net News Agency, 13 May 2026]  Shares of METIS TECHBIO-P (07666) opened at HK$28.68 in its first trading day, or 1.73 times higher than its offer price of HK$10.5.
  The stock's IPO was 6,909.96 times oversubscribed, with a board-lot winning rate of 0.14%. One lot was distributed for subscription of 800 lots. (ed)

Back to IPO News

Previous︰13/05/2026 16:08  {New Stock}METIS TECHBIO-P ends up 126.67% at HK$23.8

Next︰13/05/2026 09:20  {New Stock}IMPACT THERAP-B opens up 76.62% at HK$35.5

Other IPO News
More

13/05/2026 16:08  {New Stock}IMPACT THERAP-B ends up 108.26% at HK$41.86

13/05/2026 08:00  New Listings Memorandum

12/05/2026 18:35  {New Stock}IMPACT THERAP-B ends up 60.7% on grey market

12/05/2026 18:35  {New Stock}METIS TECHBIO-P ends up 188.76% on grey market

12/05/2026 16:20  {New Stock}IMPACT THERAP-B(07630) up 43.78% on grey market

A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2026 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.